Semiconductor equipment manufacturer Süss MicroTec delivered a jarring mix of news to its shareholders. Despite posting historic revenue figures for the fiscal year, the company announced a drastic reduction in its dividend payout. This decision, driven by significant cash outflows for Asian expansion and a cautious near-term outlook, triggered substantial volatility in the stock.
Record Sales Mask Underlying Strain
The headline numbers for the year were undeniably strong. For the first time in its history, Süss MicroTec surpassed the €500 million revenue threshold, achieving a record €503.2 million. However, the quality of this growth showed clear signs of deterioration. The gross margin contracted to 35.7%, and substantial investments at its Taiwan site pushed the free cash flow deeply negative, to minus €22.6 million.
The immediate consequence for income-focused investors is a severe dividend cut. The payout has been reduced to a mere €0.04 per share, down sharply from the previous €0.30. This fundamental shift in capital allocation sparked a fierce market reaction. At its lowest point during the trading session, the stock plummeted over 18% before finding some support. It currently trades at €47.54, reflecting a daily decline of just over 7%.
A Transition Year Ahead with Lowered Guidance
Market skepticism is being fueled primarily by management’s forecast for 2026. CEO Burkhardt Frick has characterized the coming period as a strategic transition year. During this time, the company anticipates that rising research and development expenditures will coincide with falling revenues.
Should investors sell immediately? Or is it worth buying Süss MicroTec?
The official guidance has fallen short of analyst projections. Süss MicroTec is targeting an EBIT margin between 8% and 10%, which is notably below the previous consensus estimate of 11.6%. Furthermore, management expects revenue to recede to a range of €425 million to €485 million.
Analysts Look Beyond the Current Headwinds
Financial experts are interpreting the situation with a longer-term perspective. Armin Kremser of DZ Bank points to a current digestion phase following the boom in AI-related investments. Other analysts are already looking past the current challenges. Specialists from Jefferies and Bankhaus Metzler suggest that new product introductions and expanded Asian production capacity should drive a margin recovery beginning in 2027.
To ensure financial flexibility through this investment phase, the company has proactively secured a new syndicated loan facility worth €115 million. The long-term strategic goals remain unchanged: management reaffirms its ambition to achieve up to €900 million in revenue with an EBIT margin exceeding 20% by the year 2030.
Investors will receive their next key data points on May 7th with the upcoming quarterly report, which will provide early indications of order intake in the challenging market. The board will then face shareholder questions at the annual general meeting scheduled for June 3rd.
Ad
Süss MicroTec Stock: Buy or Sell?! New Süss MicroTec Analysis from March 31 delivers the answer:
The latest Süss MicroTec figures speak for themselves: Urgent action needed for Süss MicroTec investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 31.
Süss MicroTec: Buy or sell? Read more here...
